Skip to content

Pfizer PFE Restructuring Charges

Discontinued — last reported Q1 '24

Restructuring Charges at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$32M+88.2%
Merck & Co. logo
Merck & Co.MRK
$195M+183%
Organon logo
OrganonOGN
$31M-64.0%

Segments

By segment

See full
Biopharma$47M-92.4%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Pfizer’s 10-Q, filed May 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's restructuring charges?
Pfizer (PFE) reported restructuring charges of $10M in Q1 2024.
How has Pfizer's restructuring charges changed year-over-year?
Pfizer's restructuring charges increased by 122.7% year-over-year, from -$44M to $10M.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.